In the Press

David Fyfield quoted in Pharmaceutical Journal and MedicalHealthNews on the impact of the pregabalin case for second medical use patents

David Fyfield has been quoted in Pharmaceutical Journal and MedicalHealthNews on the impact of the pregabalin case for second medical use patents.

Our thinking

Share this Page

TOP